$CTCX
Carmell Corp

2022 Q4 Form 10-K Financial Statement

#000119312523073837 Filed on March 17, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $706.6K $1.651M $369.9K
YoY Change 91.02% 253.31%
% of Gross Profit
Research & Development $2.196M
YoY Change
% of Gross Profit
Depreciation & Amortization $94.30K
YoY Change
% of Gross Profit
Operating Expenses $706.6K $1.651M $369.9K
YoY Change 91.02% 253.31%
Operating Profit -$1.651M
YoY Change
Interest Expense $1.336M $2.248M $5.440K
YoY Change 24467.83% 27683.44%
% of Operating Profit
Other Income/Expense, Net $0.00 $130.0K
YoY Change -100.0%
Pretax Income $629.9K $596.2K -$234.5K
YoY Change -368.61% -281.01%
Income Tax $391.2K $391.2K
% Of Pretax Income 62.11% 65.62%
Net Earnings $238.7K $205.0K -$234.5K
YoY Change -201.79% -162.24%
Net Earnings / Revenue
Basic Earnings Per Share -$5.47
Diluted Earnings Per Share $0.01 $0.01 -$11.40K
COMMON SHARES
Basic Shares Outstanding 1.757M
Diluted Shares Outstanding 1.757M

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.7K $187.7K $774.2K
YoY Change -75.76% -75.76%
Cash & Equivalents $187.7K $774.2K
Short-Term Investments
Other Short-Term Assets $97.54K $97.54K $199.0K
YoY Change -50.98% -50.98%
Inventory $0.00
Prepaid Expenses $97.54K $199.0K
Receivables
Other Receivables
Total Short-Term Assets $285.2K $285.2K $973.2K
YoY Change -70.69% -70.69%
LONG-TERM ASSETS
Property, Plant & Equipment $255.0K
YoY Change
Goodwill $0.00
YoY Change
Intangibles
YoY Change
Long-Term Investments $156.7M $156.7M $154.4M
YoY Change 1.45% 1.45%
Other Assets
YoY Change
Total Long-Term Assets $156.7M $156.7M $154.4M
YoY Change 1.45% 1.45%
TOTAL ASSETS
Total Short-Term Assets $285.2K $285.2K $973.2K
Total Long-Term Assets $156.7M $156.7M $154.4M
Total Assets $157.0M $157.0M $155.4M
YoY Change 1.0% 1.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.139M
YoY Change
Accrued Expenses $1.258M $1.258M $215.2K
YoY Change 484.6% 283.96%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.682M $1.682M $330.0K
YoY Change 409.54% 409.53%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $5.405M $5.405M $5.405M
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $5.405M $5.405M $5.405M
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.682M $1.682M $330.0K
Total Long-Term Liabilities $5.405M $5.405M $5.405M
Total Liabilities $7.087M $7.087M $5.735M
YoY Change 23.56% 23.56%
SHAREHOLDERS EQUITY
Retained Earnings -$6.018M -$4.763M
YoY Change 26.36%
Common Stock $894.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$6.018M $149.9M -$4.762M
YoY Change
Total Liabilities & Shareholders Equity $157.0M $157.0M $155.4M
YoY Change 1.0% 1.0%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income $238.7K $205.0K -$234.5K
YoY Change -201.79% -162.24%
Depreciation, Depletion And Amortization $94.30K
YoY Change
Cash From Operating Activities -$189.2K -$488.7K -$70.93K
YoY Change 166.69% 8.33%
INVESTING ACTIVITIES
Capital Expenditures $7.164K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 -97.79K -4.530K
YoY Change -100.0% -100.06%
NET CHANGE
Cash From Operating Activities -189.2K -488.7K -70.93K
Cash From Investing Activities 0.000 0.000 0.000
Cash From Financing Activities 0.000 -97.79K -4.530K
Net Change In Cash -189.2K -586.5K -75.46K
YoY Change 150.68% -175.76%
FREE CASH FLOW
Cash From Operating Activities -$189.2K -$488.7K -$70.93K
Capital Expenditures $7.164K
Free Cash Flow -$495.9K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
alpa Proceeds From Issuance Of Private Placement Unit
ProceedsFromIssuanceOfPrivatePlacementUnit
4638820
CY2022 dei Auditor Firm
AuditorFirmId
3686
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001842939
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-40228
CY2022 dei Entity Registrant Name
EntityRegistrantName
Alpha Healthcare Acquisition Corp. III
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
85-1645738
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
1177 Avenue of the Americas
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
5th Floor
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10036
CY2022 dei City Area Code
CityAreaCode
646
CY2022 dei Local Phone Number
LocalPhoneNumber
494-3296
CY2022 dei Security12b Title
Security12bTitle
Class A Common Stock, par value $0.0001 per share
CY2022 dei Trading Symbol
TradingSymbol
ALPA
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022Q4 dei Entity Public Float
EntityPublicFloat
148572270000000
CY2022 dei Auditor Name
AuditorName
Adeptus Partners, LLC
CY2022 dei Auditor Location
AuditorLocation
Ocean, NJ
CY2022Q4 us-gaap Cash
Cash
187664
CY2021Q4 us-gaap Cash
Cash
774192
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
97538
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
198983
CY2022Q4 us-gaap Assets Current
AssetsCurrent
285202
CY2021Q4 us-gaap Assets Current
AssetsCurrent
973175
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
156693598
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
154449121
CY2022Q4 us-gaap Assets
Assets
156978800
CY2021Q4 us-gaap Assets
Assets
155422296
CY2022Q4 alpa Accrued Offering Costs
AccruedOfferingCosts
0
CY2021Q4 alpa Accrued Offering Costs
AccruedOfferingCosts
112485
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1258337
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
215247
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
31979
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2275
CY2022Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
391198
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1681514
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
330007
CY2022Q4 alpa Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
CY2021Q4 alpa Deferred Underwriting Fees Payable Noncurrent
DeferredUnderwritingFeesPayableNoncurrent
5405436
CY2022Q4 us-gaap Liabilities
Liabilities
7086950
CY2021Q4 us-gaap Liabilities
Liabilities
5735443
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6018111
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4762700
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6017679
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
156978800
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
155422296
CY2022 alpa Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
1651483
alpa Formation General And Administrative Expenses
FormationGeneralAndAdministrativeExpenses
467431
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
-1651483
us-gaap Operating Income Loss
OperatingIncomeLoss
-467431
CY2022 alpa Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
2247678
alpa Interest And Dividend Income Non Operating
InterestAndDividendIncomeNonOperating
8091
CY2022 alpa Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
0
alpa Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
2923
CY2022 alpa Gain On Expiration Of Overallotment Option
GainOnExpirationOfOverallotmentOption
0
alpa Gain On Expiration Of Overallotment Option
GainOnExpirationOfOverallotmentOption
127035
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
596195
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-329382
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
391198
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Net Income Loss
NetIncomeLoss
204997
us-gaap Net Income Loss
NetIncomeLoss
-329382
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
CY2022 alpa Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-1460408
CY2022 us-gaap Net Income Loss
NetIncomeLoss
204997
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-6017679
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
0
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
25000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1186448
alpa Adjustments To Additional Paid In Capital Fair Value Of Underwriter Overallotment Options Exercised
AdjustmentsToAdditionalPaidInCapitalFairValueOfUnderwriterOverallotmentOptionsExercised
28317
alpa Accretion To Redemption Value Of Class A Common Stock Subject To Possible Redemption
AccretionToRedemptionValueOfClassACommonStockSubjectToPossibleRedemption
-13702512
alpa Change In Value Of Temporary Equity Due To Dividend And Interest Earned
ChangeInValueOfTemporaryEquityDueToDividendAndInterestEarned
-8091
us-gaap Net Income Loss
NetIncomeLoss
-329382
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-4762268
us-gaap Stock Issued During Period Shares Share Based Compensation Forfeited
StockIssuedDuringPeriodSharesShareBasedCompensationForfeited
451474
CY2022 us-gaap Profit Loss
ProfitLoss
204997
us-gaap Profit Loss
ProfitLoss
-329382
CY2022 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2244477
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
8091
CY2022 alpa Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
0
alpa Change In Fair Value Of Overallotment Liability
ChangeInFairValueOfOverallotmentLiability
2923
CY2022 alpa Gain On Expiration Of Overallotment Option
GainOnExpirationOfOverallotmentOption
0
alpa Gain On Expiration Of Overallotment Option
GainOnExpirationOfOverallotmentOption
127035
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-101445
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
198983
CY2022 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
1028390
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
215247
CY2022 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
29704
us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
0
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-488743
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-451167
CY2022 alpa Investment Of Cash Into Trust Account
InvestmentOfCashIntoTrustAccount
0
alpa Investment Of Cash Into Trust Account
InvestmentOfCashIntoTrustAccount
-154441030
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
56922
CY2022 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
0
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
54647
CY2022 us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
0
us-gaap Proceeds From Issuance Of Common Limited Partners Units
ProceedsFromIssuanceOfCommonLimitedPartnersUnits
154441030
CY2022 alpa Proceeds From Issuance Of Private Placement Unit
ProceedsFromIssuanceOfPrivatePlacementUnit
0
CY2022 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
97785
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3415736
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-97785
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
155666389
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-586528
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
774192
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
774192
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
187664
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
774192
CY2022 alpa Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Common Stock
OfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBCommonStock
0
alpa Offering Costs Paid By Sponsor In Exchange For Issuance Of Class B Common Stock
OfferingCostsPaidBySponsorInExchangeForIssuanceOfClassBCommonStock
25000
CY2022 alpa Capital Contribution By The Sponsor Through Transfer Of Class B Shares
CapitalContributionByTheSponsorThroughTransferOfClassBShares
0
alpa Capital Contribution By The Sponsor Through Transfer Of Class B Shares
CapitalContributionByTheSponsorThroughTransferOfClassBShares
1186448
CY2022 alpa Offering Costs Included In Accrued Offerings Costs And Expenses
OfferingCostsIncludedInAccruedOfferingsCostsAndExpenses
0
alpa Offering Costs Included In Accrued Offerings Costs And Expenses
OfferingCostsIncludedInAccruedOfferingsCostsAndExpenses
112485
CY2022 alpa Deferred Underwriting Commissions
DeferredUnderwritingCommissions
0
alpa Deferred Underwriting Commissions
DeferredUnderwritingCommissions
5405436
CY2022Q4 alpa Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
1460408
CY2021Q4 alpa Accretion Of Interest Earned In The Trust Account Accrued To Temporary Equity Shareholders
AccretionOfInterestEarnedInTheTrustAccountAccruedToTemporaryEquityShareholders
8091
CY2022 alpa Restricted Investments Term
RestrictedInvestmentsTerm
P185D
CY2022 alpa Lock In Period For Redemption Of Public Shares After Closing Of Ipo
LockInPeriodForRedemptionOfPublicSharesAfterClosingOfIpo
P24M
CY2022Q4 alpa Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022Q4 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.50
CY2021Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q4 alpa Percentage Of Public Shares To Be Redeemed In Case Business Combination Is Not Consummated
PercentageOfPublicSharesToBeRedeemedInCaseBusinessCombinationIsNotConsummated
1
CY2022Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10
CY2022Q4 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2022Q4 us-gaap Cash
Cash
187664
CY2022 alpa Maximum Net Interests To Pay Dissolution Expenses
MaximumNetInterestsToPayDissolutionExpenses
100000
CY2022Q4 us-gaap Cash
Cash
187664
CY2022Q4 alpa Negative Working Capital
NegativeWorkingCapital
-1396312
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6018111
CY2022Q4 us-gaap Cash
Cash
187664
CY2022Q4 alpa Volume Weighted Average Price Of Shares
VolumeWeightedAveragePriceOfShares
9.2
CY2022 alpa Proceeds From Equity Used For Funding Business Combination As A Percentage Of The Total
ProceedsFromEquityUsedForFundingBusinessCombinationAsAPercentageOfTheTotal
0.60
CY2022 alpa Notice Period Of Redemption Warrant
NoticePeriodOfRedemptionWarrant
P30D
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
391198
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:9%; font-size:10pt; font-family:Times New Roman">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div>
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.65
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 alpa Fair Value Of Overallotment Liability At The Initial Public Offering Date
FairValueOfOverallotmentLiabilityAtTheInitialPublicOfferingDate
158275
CY2021Q3 alpa Fair Value Of Overallotment Liability Partially Extinguished Upon Exercise Of Option
FairValueOfOverallotmentLiabilityPartiallyExtinguishedUponExerciseOfOption
28317
CY2021Q3 alpa Gain On Expiration Of Overallotment Option
GainOnExpirationOfOverallotmentOption
127035
CY2022 alpa Offering Costs Incurred
OfferingCostsIncurred
92070
CY2022Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
156693598
CY2021Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
154449121
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-top: 0pt; margin-bottom: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"><div style="font-weight:bold;display:inline;"><div style="font-style: italic; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div><div style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Financial instruments that potentially subject the Company to a concentration of credit risk consist of a cash account in a financial institution, which at times may exceed the Federal Depository Insurance Corporation coverage limit of $250,000. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account. </div>
CY2022Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
31979
CY2022 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
1979
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
2275
CY2022 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
1:1.2
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
1000000
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
391198
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-265998
us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-96461
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-265998
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-96461
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
391198
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
33531
CY2022Q4 alpa Deferred Tax Assets Organizational Costs Startup Expenses
DeferredTaxAssetsOrganizationalCostsStartupExpenses
-362459
CY2021Q4 alpa Deferred Tax Assets Organizational Costs Startup Expenses
DeferredTaxAssetsOrganizationalCostsStartupExpenses
-62930
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
362459
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
96461
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
362459
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
96461
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-265998
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-96461
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2022Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2021Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2022 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2022 alpa Effective Income Tax Rate Reconciliation Change In Fair Value Of Overallotment Liability
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfOverallotmentLiability
0
alpa Effective Income Tax Rate Reconciliation Change In Fair Value Of Overallotment Liability
EffectiveIncomeTaxRateReconciliationChangeInFairValueOfOverallotmentLiability
0.083
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.44
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.293
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0.65
us-gaap Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate
EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0
CY2022 alpa Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsExercisedInPeriod
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
0
CY2022Q4 alpa Fair Value Of Founder Shares On The Grant Date
FairValueOfFounderSharesOnTheGrantDate
5.26

Files In Submission

Name View Source Status
0001193125-23-073837-index-headers.html Edgar Link pending
0001193125-23-073837-index.html Edgar Link pending
0001193125-23-073837.txt Edgar Link pending
0001193125-23-073837-xbrl.zip Edgar Link pending
alpa-20221231.xsd Edgar Link pending
d455133d10k.htm Edgar Link pending
d455133dex311.htm Edgar Link pending
d455133dex312.htm Edgar Link pending
d455133dex321.htm Edgar Link pending
d455133dex322.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
alpa-20221231_cal.xml Edgar Link unprocessable
alpa-20221231_def.xml Edgar Link unprocessable
alpa-20221231_lab.xml Edgar Link unprocessable
alpa-20221231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
d455133d10k_htm.xml Edgar Link completed